Table 2 Patient characteristics at the time of HCT-ASCT.

Delay between initial diagnosis and HCT-ASCT: median (range), months

21.6 (4.9–116.3)

Delay between isolated ophthalmological relapse (or diagnosis for HCT-ASCT in the 1^st line) and HCT-ASCT: median (range), months

4.9 (2.6–7.2)

Age at HCT-ASCT, median [Min-Max]

61 [42–73]

KPS, median [Min, Max] at HCT-ASCT

90 [60,100]

Mean best corrected visual acuity at HCT-ASCT (decimal scale)

6.33 ± 2.26

 Complete response

29 (76%)

 Partial response

7 (18%)

 Stable disease

1 (3%)

 Progressive disease

1 (3%)

 Number of dosages available

13 (34%)

 IL-10 level (pg/ml): median (Min-Max)

10 (0–265)

 Elevated IL-10 (>30 pg/ml)

5/13 (38%)

 IL-10/IL-6 ratio >1

6/13 (46%)